COMAS expands its intellectual property portfolio with a new PCT patent application filing

The Patent Cooperation Treaty (PCT) [PDF] ​​​​​​​ is an international treaty administered by WIPO. It establishes an international patent system that helps companies and innovators seek patent protection in multiple countries through a single, cost-effective procedure. Under the PCT System, you can file one PCT application, in one language, at one patent Office (“receiving Office”), while having the same legal effect as filing separate patent applications in all Contracting States of the Treaty.

In September, 2026 COMAS filed a new PCT application using the USPTO covering aspects of the COMAS system including software and hardware related to the main control unit and the different configurations of the patch. The PCT application filing, if granted, will allow COMAS to designate and seek registration of the patent with any of the currently 159 national patent offices that are members of the PCT that we feel match our business strategy as we move forward. We will have 30 months to make those decisions from the date of our provisional application filed in September 2025.

COMAS Medical Technologies AB patent portfolio currently includes 7 patent families with a total of 21 individuals; 19 applications and 2 granted patents, the oldest of which is the core COMAS US patent which was granted in July of 2017 with an extended expiration date of August 16th, 2034. In certain cases we have exclusive global licenses in the field of wound care and prevention for externaly developed technologies that compliment our own technologies. COMAS will continue to expand our intellectual property portfolio to maintain a robust arsenal to protect our market position in the US, the EU and wider international markets.